Lonza Reports Rise in First-Half Profits

Lonza has recorded a 14.4% rise in first-half profits, to SF135 million ($130 million), compared to the year-ago period, and Ebitda increased by 3%, to SF309 million. Sales however decreased by 2%, to SF1.3 billion, mainly due to an expectedly weak first quarter in custom manufacturing, Lonza says. The Life Science Ingredients business recorded a 5.9% increase in sales in the first half, to SF536 million, compared with the year-ago period, and Ebit for the business increased by 17.4% to SF81 million. Volumes recovered in almost all end-markets except agchems...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers